Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranolazine for Angina in PCI-Deferred Patients
NCT02147834Phase 2Terminated
- Sponsor
- North Florida Foundation for Research and Education
- Start
- Aug 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ranolazine in angina pectoris, sponsored by North Florida Foundation for Research and Education. Started Aug 2015; status: terminated.
02
Drugs
ranolazine
03
Conditions
angina pectoris
Beyond the preview
Go deeper on NCT02147834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02147834.